Global Losartan Potassium Tablets Market Size, Share, and COVID-19 Impact Analysis, By Strength (25 mg, 50 mg, and 100 mg), By Indication (Hypertension, Heart Failure, Chronic Kidney Disease, and Others), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 - 2035

Global Losartan Potassium Tablets Market Insights Forecasts to 2035

• The Global Losartan Potassium Tablets Market Size Was Estimated at USD 2.66 Billion in 2024
• The Market Size is Expected to Grow at a CAGR of around 6.3% from 2025 to 2035
• The Worldwide Losartan Potassium Tablets Market Size is Expected to Reach USD 5.21 Billion by 2035
• Asia Pacific is expected to grow the fastest during the forecast period.

According to a research report published by Spherical Insights and Consulting, The Global Losartan Potassium Tablets Market Size was worth around USD 2.66 Billion in 2024 and is predicted to grow to around USD 5.21 Billion by 2035 with a compound annual growth rate (CAGR) of 6.3% from 2025 to 2035. The market for losartan potassium tablets is expanding with the increasing incidence of cardiovascular diseases and hypertension, rising awareness regarding the treatment modalities, and availability of generic versions. Further, government healthcare policies that support such initiatives and improvements in drug delivery systems also lead to increasing patient accessibility and market growth.

Global Losartan Potassium Tablets Market Forecast and Revenue Outlook

• 2024 Market Size: USD 2.66 Billion
• 2035 Projected Market Size: USD 5.21 Billion
• CAGR (2025-2035): 6.3%
• North America: Largest market in 2024
• Asia Pacific: Fastest growing market

Market Overview

The losartan potassium tablets business refers to the production and distribution of losartan potassium, an angiotensin II receptor antagonist (ARA) or ARB, used extensively in the management of hypertension, prevention of stroke, and treatment of chronic kidney disease and heart failure. Losartan potassium tablets lower blood pressure and cardiovascular disease risk by lowering the tension in the arteries. The increasing incidence of hypertension and cardiovascular disorders worldwide is one of the key drivers for market growth, as physicians are prescribing losartan in increasing numbers due to its safety and efficacy. Moreover, increased awareness of controlling hypertension and increasing the population of geriatric people also requires losartan potassium tablets.

Growth opportunities in the market are further boosted by continuous research to formulate better drugs with high bioavailability and minimal side effects. For this purpose, the growing application of the generic form of losartan has priced the drug cheaper, once again boosting market penetration, especially in developing economies. Large pharmaceutical firms such as Merck, Cipla, Sun Pharma, and Teva Pharmaceuticals stock the market with large-scale manufacturing outlets and channels, making the market a stocked one, such that the drug is readily available everywhere. In March 2025, Arbli, a ready-to-use liquid losartan potassium formulation, was approved by the U.S. FDA, providing consistent dosing without tablet crushing, safe, and convenient. It has an 18-month shelf life at room temperature, addressing the needs of patients in need of liquid medication.

Key Market Insights

• North America is expected to account for the largest share in the losartan potassium tablets market during the forecast period.
• In terms of strength, the 50 mg segment is projected to lead the losartan potassium tablets market throughout the forecast period
• In terms of indication, the hypertension segment captured the largest portion of the market

Losartan Potassium Tablets Market Trends

• Growing elderly population boosts market growth due to higher hypertension prevalence.
• Rising hypertension cases are increasing the demand for losartan potassium tablets.
• Innovations in drug formulations improve patient compliance and treatment outcomes.
• Availability of generic losartan tablets expands market accessibility globally.
• Increased awareness about cardiovascular health drives losartan consumption.

Report Coverage

This research report categorizes the losartan potassium tablets market based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. The report analyzes the key growth drivers, opportunities, and challenges influencing the losartan potassium tablets market. Recent market developments and competitive strategies, such as expansion, type launch, development, partnership, merger, and acquisition, have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyzes their core competencies in each sub-segment of the losartan potassium tablets market.

Driving factors

Increased prevalence of hypertension, an increasing geriatric population, increased awareness, and development in drug forms fuel the growth in losartan potassium tablets. Increased prevalence of hypertension raises demand for effective therapies such as losartan potassium tablets. The aging population plays a vital role in market growth, with the United Nations projecting the global population aged 60 and above to double, reaching 2.1 billion by 2050. Furthermore, progress in drug composition enhances effectiveness, patient adherence, and minimizes side effects, further making losartan potassium tablets increasingly attractive to healthcare professionals and patients alike, propelling market growth.

Restraining Factor

High treatment costs, side effects, strict regulations, and limited patient adherence restrain market growth. Treatment affordability constraints limit patients' use of losartan potassium tablets. Side effects can lead to discontinuation by patients. Stringent laws retard drug approval and market access. Low patient compliance, resulting from dosing complexity or forgetfulness, lowers treatment efficacy, inhibiting market growth.

Market Segmentation 

The global losartan potassium tablets market is divided into strength and indication.

Global Losartan Potassium Tablets Market, By Strength:

• The 50 mg segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period.  

Based on strength, the global losartan potassium tablets market is segmented into 25 mg, 50 mg, and 100 mg. Among these, the 50 mg segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period. The market is dominated by the 50 mg strength due to its widespread application as the initiation dose for the treatment of hypertension. It works with the majority of patients and is easily titratable according to tolerance and response, which makes it a favorite among healthcare professionals for the treatment of hypertension.

The 100 mg segment in the losartan potassium tablets market is expected to grow at the fastest CAGR over the forecast period. The 100 mg dose is recommended for patients requiring more potent antihypertensive action, particularly in the case of severe hypertension or chronic kidney disease. The increasing incidence and awareness of its advantages among certain groups are driving demand for this high dose.

Global Losartan Potassium Tablets Market, By Indication:

• The hypertension segment accounted for the largest share in 2024 and is anticipated to grow at a significant CAGR during the forecast period.

Based on indication, the global losartan potassium tablets market is segmented into hypertension, heart failure, chronic kidney disease, and others. Among these, the hypertension segment accounted for the largest share in 2024 and is anticipated to grow at a significant CAGR during the forecast period. The hypertension segment is attributed to the rising worldwide prevalence of high blood pressure. Increased awareness regarding hypertension control, an ageing population, and enhanced diagnosis rates support the growth of the segment. Moreover, the efficacy of losartan potassium tablets in regulating blood pressure and avoiding cardiovascular disease complications drives the segment's strong CAGR throughout the forecasting period.

The heart failure segment in the losartan potassium tablets market is expected to grow at the fastest CAGR over the forecast period. The heart failure segment plays an important role in the market as losartan lowers hospitalization and death rates. Increasing cases of heart failure, fueled by ageing populations and rising hypertension and diabetes cases, are anticipated to drive demand for losartan potassium tablets in this region.

Regional Segment Analysis of the Global Losartan Potassium Tablets Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

North America Losartan Potassium Tablets Market Trends

North America is expected to hold the largest share of the global losartan potassium tablets market over the forecast period.

North America is dominating the global market for losartan potassium tablets, owing to its advanced healthcare infrastructure and high incidence of hypertension and cardiovascular diseases. The region is also supported by a strong government support system, global awareness of hypertension control, and major pharma companies investing significantly in research and development. Nearly half of the adults residing in the United States have hypertension, as reported by the Centers for Disease Control and Prevention (CDC), which emphasizes the heavy need for drugs that treat hypertension, such as Losartan.

U.S. Losartan Potassium Tablets Market Trends

The U.S. losartan potassium tablets market trends with increasing hypertension rate, aging population growth, rising awareness of cardiovascular health, drug formulation improvements, robust healthcare infrastructure, supportive regulatory conditions, and high investments of drug companies in cell and gene therapy research.

Asia Pacific Losartan Potassium Tablets Market Trends

Asia Pacific is expected to grow at the fastest CAGR in the losartan potassium tablets market during the forecast period. The Asia Pacific is rapidly growing in the losartan potassium tablets market based on the growing population of the region, rising incidence of hypertension and cardiovascular ailments, and the growing geriatric population, base strongly propels demand. Growing healthcare awareness levels and enhanced healthcare infrastructure further fuel market growth. Furthermore, rising government support and supportive regulatory guidelines also encourage increased access to affordable drugs. The presence of up and coming economies such as India and China with growing pharmaceutical manufacturing capabilities is also supportive. Increasing expenditure on research and development, along with rising disposable incomes, improves the market growth potential in the region.

India Losartan Potassium Tablets Market Trends

Market growth of India's losartan potassium tablets is fueled by an increase in hypertension cases, growing health infrastructure, rising awareness of cardiovascular health, and promotional initiatives by the government to improve access to affordable medications. A rising geriatric population and better diagnostic facilities also contribute to market growth.

China Losartan Potassium Tablets Market Trends

China's losartan potassium tablets market growth is propelled by growing hypertension incidence, rising health investments, growing pharmaceutical production, government initiatives in chronic disease management, and awareness of effective cardiovascular therapy.

Japan Losartan Potassium Tablets Market Trends

Japan's losartan potassium tablets market growth is propelled by a growing population, elevated hypertension incidence, superior healthcare infrastructure, growing government efforts in chronic disease management, and growing uptake of innovative drug formats.

Europe Losartan Potassium Tablets Market Trends

Europe's losartan potassium tablets market is expanding due to the growing prevalence of hypertension, a growing aged population, and improving healthcare infrastructure. Government campaigns for chronic disease management and awareness, and rising usage of generic losartan tablets and enhanced reimbursement policies are also contributing to market growth in the region.

France Losartan Potassium Tablets Market Trends

The France losartan potassium tablets market is fueled by increased rates of hypertension, government healthcare programs supporting cardiovascular disease control, a rising geriatric population, and growing awareness of the affordability of generic medication.

U.K. Losartan Potassium Tablets Market Trends

The U.K. losartan potassium tablets market is expanding owing to increased prevalence of hypertension, a well-developed healthcare sector, a higher geriatric population, government support for cardiovascular wellness, and increased demand for affordable generic drugs.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the global losartan potassium tablets market, along with a comparative evaluation primarily based on their type of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborate analysis focusing on the current news and developments of the companies, which includes type development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

Worldwide Top Key Players In The Losartan Potassium Tablets Market Include

• Merck & Co.
• Teva Pharmaceutical Industries Ltd.
• Pfizer Inc.
• Zydus Lifesciences Ltd.
• Sanofi S.A.
• Mylan N.V.
• Dr. Reddy's Laboratories
• Lupin Limited
• Novartis International AG
• Aurobindo Pharma Limited
• Torrent Pharmaceuticals
• Sun Pharmaceutical Industries Limited
• Others  

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent development

• In May 2025, Teva Pharmaceutical launched its Pivot to Growth strategy, outlining plans to become a global biopharmaceutical leader, focusing on innovation, portfolio priorities, and long-term shareholder value through 2030 and beyond.
• In May 2025, Lupin Limited announced the U.S. launch of Tolvaptan Tablets in multiple strengths after receiving FDA approval, securing 180-day exclusivity as the first-to-file generic manufacturer for the product.
• In March 2025, Scienture Holdings, Inc. announced that the U.S. FDA approved SCN 102, branded as Arbli (losartan potassium) Oral Suspension, 10 mg/mL. Developed by its subsidiary, Scienture, LLC, Arbli addresses unmet needs with a novel liquid formulation for patients requiring alternative dosing options.
• In March 2025, Novartis announced a strategic partnership aimed at expanding its global losartan potassium tablets portfolio through collaborative manufacturing and distribution agreements, enhancing accessibility and market presence across multiple regions.
• In July 2024, Zydus Lifesciences received final USFDA approval to market Sacubitril and Valsartan Tablets in various strengths, a generic version of Entresto for heart failure treatment in the U.S.

Market Segment

This study forecasts revenue at the global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the losartan potassium tablets market based on the following segments:

 Global Losartan Potassium Tablets Market, By Strength

• 25 mg
• 50 mg
• 100 mg

Global Losartan Potassium Tablets Market, By Indication

• Hypertension
• Heart Failure
• Chronic Kidney Disease
• Others

Global Losartan Potassium Tablets Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa